Cancer News and Research RSS Feed - Cancer News and Research Twitter

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Treatment plans may include surgery, radiation and/or chemotherapy.
Study finds a host of new clues on gene-environment interactions in Crohn's disease

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America. [More]
Memorial Hermann, MD Anderson partner to provide breast screening services in greater Houston area

Memorial Hermann, MD Anderson partner to provide breast screening services in greater Houston area

Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area. [More]
ESMO announces names of outstanding individuals receiving annual awards

ESMO announces names of outstanding individuals receiving annual awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid. [More]
Study: Low birth weight may put African American women at higher risk for type 2 diabetes

Study: Low birth weight may put African American women at higher risk for type 2 diabetes

African American women born at a low or very low birth weight may be at a higher risk for developing type 2 diabetes. The findings, which appear in Diabetes Care, may explain in part the higher occurrence of type 2 diabetes in African American populations, which has a high prevalence of low birth weight. [More]
Sen. Pryor debuts campaign ad embracing health law provisions

Sen. Pryor debuts campaign ad embracing health law provisions

The Arkansas Democrat, who is in a tough reelection fight, talked about his own struggle with cancer and how the health law provisions that prohibit insurance companies from denying coverage to people with medical problems could have helped him. [More]
ZERO hosts 16 run/walk events to raise funds, awareness to end prostate cancer

ZERO hosts 16 run/walk events to raise funds, awareness to end prostate cancer

ZERO – The End of Prostate Cancer is hosting 16 run/walk events across the nation during September, Prostate Cancer Awareness Month, to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. [More]
Novel "man and machine" decision support system for diagnosing malaria infection

Novel "man and machine" decision support system for diagnosing malaria infection

A Finnish-Swedish research group at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, and Karolinska institutet, Stockholm, has developed a novel "man and machine" decision support system for diagnosing malaria infection. [More]
Study shows new role for protein APC in suppressing colorectal cancer

Study shows new role for protein APC in suppressing colorectal cancer

A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer - the second-leading cause of cancer-related deaths in the U.S. [More]
Baxter reports positive results from BAX 855 Phase 3 trial for hemophilia A

Baxter reports positive results from BAX 855 Phase 3 trial for hemophilia A

Nektar Therapeutics reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)], which met its primary endpoint in reducing annualized bleed rates (ABR) in the prophylaxis arm compared to the on-demand arm. [More]
Memorial Hermann partners with MD Anderson to provide new level of specialized breast screening

Memorial Hermann partners with MD Anderson to provide new level of specialized breast screening

Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area. [More]
Study links gum disease to lung disease, cancer and heart failure

Study links gum disease to lung disease, cancer and heart failure

Most people are very familiar with the reality that, if they don't practice regular brushing and overall good dental hygiene, they are at risk for developing gum disease. Less well known is the full extent of the potential harm caused by gum disease. [More]
CEA launches new epilepsy comic book for children

CEA launches new epilepsy comic book for children

The Canadian Epilepsy Alliance is thrilled to announce the launch of a new comic series designed to educate children about the most common neurological disorder in Canada, epilepsy. The Medikidz Explain Epilepsy comic series tells a fictional story based on the experiences of 14-year-old Jack, who is navigating middle school while living with epilepsy. [More]
Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Preoperative imaging could help guide the use of postoperative adjuvant chemotherapy in patients with early non-small-cell lung cancer, Japanese researchers believe. [More]
Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib is a valid treatment option for patients with KRAS wild-type lung adenocarcinoma refractory to chemotherapy, study data show. [More]
First Edition: August 21, 2014

First Edition: August 21, 2014

Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates. [More]
Viewpoints: Threat to drug development; GOP's Obamacare criticism tempered; finding doctors for seniors

Viewpoints: Threat to drug development; GOP's Obamacare criticism tempered; finding doctors for seniors

An invasive species has been introduced into the U.S. health innovation ecosystem, with a growing danger of permanent damage to the development of specialty drugs. [More]
Majority of states not measuring up on legislative solutions that fight cancer, shows report

Majority of states not measuring up on legislative solutions that fight cancer, shows report

A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). [More]

Walgreens' billion-dollar Medicare-biz forecasting mistake

Also, the Wall Street Journal examines the collapse of the Vascular Biogenics initial public offering. A billion-dollar forecasting error in Walgreen Co.'s Medicare-related business has cost the jobs of two top executives and alarmed big investors. [More]
Plymouth University selects Brain Tumour Research as official charity partner

Plymouth University selects Brain Tumour Research as official charity partner

Brain Tumour Research has been chosen by Plymouth University to be an official charity partner. Brain Tumour Research was launched in April 2009 to raise awareness of, and funding for, scientific research into brain tumours and improve outcomes for brain tumour patients. [More]
Investigational drug focuses on slowing Alzheimer's disease progression

Investigational drug focuses on slowing Alzheimer's disease progression

Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that. [More]